The global CRISPR market is anticipated to grow at a considerable CAGR of 36.8 % during the forecast period. Several researchers showed that a gene-editing tool called CRISPR could alter the DNA of human cells like a very precise and easy-to-use pair of scissors. The various launches and development in CRISPR technology are propelling the growth of the market during the forecast. For instance, in March 2021, Scientists at UC San Francisco, UC Berkeley, and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells. The trial will combine CRISPR technology developed at Innovative Genomics Institute (IGI) — a joint UC Berkeley-UCSF initiative founded by Berkeley’s Nobel Prize-winning scientist Jennifer Doudna, Ph.D. — with UCLA’s expertise in genetic analysis and cell manufacturing, and the decades-long expertise at UCSF Benioff Children’s Hospital Oakland in cord blood and marrow transplantation and gene therapy for sickle cell disease.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/crispr-market
- For instance, in October 2020, Jennifer Doudna’s new gene-editing Company announced a collaboration with Biogen to develop CRISPR-based genetic medicines for neurological diseases, including Amyotrophic Lateral Sclerosis (ALS). CRISPR, you may remember, is a powerful tool used to control the genes (or genetic instructions) that are active in plants, animals, and even humans. With CRISPR gene editing, researchers can “silence” undesirable traits, and, potentially, add desirable traits.
- For instance, in June 2020, Merck, a leading science and technology company, and 10x Genomics, Inc. a single cell and spatial genomics Technologies Company announced that they have developed a powerful new option for biological experiments. The companies will work together as part of 10x Genomics’ 10x Compatible Partnership Program, a global ecosystem of technologies and solutions that provide customers with the ability to enhance their unique research applications and accelerate discovery.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Application
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Caribou Bioscience Inc., Cellectis SA, CRISPR Therapeutics AG, Editas Medicine, Inc., Genscript Biotech Corp., Horizon Discovery Ltd., Lonza Group Ltd., Merck KGaA, Darmstadt, Origene Technologies, and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global CRISPR Market Report Segment
By Application
- Cell Line Engineering
- CRISPR plasmid
- Gene Database/ Gene Library
- Genetic Engineering
- Genetically Modified Organisms Or Crops
- Genome Editing
- Human Stem Cells
By End-User
- Academic Institutes
- Biotechnology Companies
- Pharmaceuticals Companies
- Research And Development Institutes
A full report of CRISPR Market is available at: https://www.omrglobal.com/industry-reports/crispr-market
CRISPR Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Addgene
- AstraZeneca PLC
- Bio-Rad Laboratories, Inc.
- Caribou Bioscience Inc.
- Cellectics SA
- Crispr Therapeutics AG
- Editas Medicine, Inc.
- Genscript Biotech Corp.
- Horizon Discovery Ltd.
- Integrated DNA Technologies, Inc.
- Intellia Therapeutics Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
